Ashay Karpe
Mumbai, MH 400092, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
CAR-T in relapsed refractory high-grade glioma and glioblastoma - who, what, when and how?
Journal: Ecancermedicalscience
Published: April 22, 2025
Outcomes of selective neck dissection in node positive oral cavity squamous cell carcinoma.
Journal: The British journal of oral & maxillofacial surgery
Published: February 11, 2025
Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.
Journal: Cancer letters
Published: January 16, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi Method.
Journal: South Asian journal of cancer
Published: September 28, 2024
Reclassifying cT4b buccal mucosa/gingivobuccal complex cancers: do we need to change?
Journal: The British journal of oral & maxillofacial surgery
Published: January 03, 2024
Role of Selective Neck Dissection in Clinically Single Node Positive Disease in Oral Cavity Cancers.
Role of Selective Neck Dissection in Clinically Single Node Positive Disease in Oral Cavity Cancers.
Journal: Indian journal of surgical oncology
Published: July 16, 2022
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients.
Journal: South Asian journal of cancer
Published: November 16, 2018
Outcomes in Treatment-Naïve Patients With Metastatic Extremity Osteosarcoma Treated With OGS-12, a Novel Non-High-Dose Methotrexate-Based, Dose-Dense Combination Chemotherapy, in a Tertiary Care Cancer Center.
Journal: Journal of global oncology
Published: September 23, 2018
Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach.
Journal: Journal of global oncology
Published: September 23, 2018
Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?
Journal: Lung India : official organ of Indian Chest Society
Published: January 11, 2018
Development and validation of a predictive score, for identifying poor eastern cooperative oncology group performance status (performance status 3-4) advanced nonsmall cell lung cancer patients who are likely to benefit from tyrosine kinase inhibitors.
Journal: Indian journal of cancer
Published: December 05, 2017
Last Updated: 09/26/2026